| Q57805541 | A halo may lead the way |
| Q36596893 | A prospective study on the prevalence and risk factors of poststroke depression |
| Q48892694 | Actigraphic measurement of motor deficits in acute ischemic stroke |
| Q48552186 | Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity. |
| Q38005465 | Acute stroke management in patients taking dabigatran. |
| Q36079045 | Admission hyperglycemia and outcome after intravenous thrombolysis: is there a difference among the stroke-subtypes? |
| Q53466775 | Apraxic agraphia following a right cerebellar hemorrhage. |
| Q92649685 | Association Between Spinal Cord Stimulation and Top-Down Nociceptive Inhibition in People With Failed Back Surgery Syndrome: A Cohort Study |
| Q51573640 | Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. |
| Q57805547 | Biochemical Markers for Blood-Brain Barrier Dysfunction in Acute Ischemic Stroke Correlate with Evolution and Outcome |
| Q57805661 | Biochemical validation of a rat model for polycystic kidney disease: Comparison of guanidino compound profile with the human condition |
| Q57805681 | Book review |
| Q44035299 | Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients |
| Q34767436 | Cerebellar cognitive affective syndrome without global mental retardation in two relatives with Gillespie syndrome |
| Q89305103 | Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial |
| Q49031559 | Cerebral Blood Flow and Heart Rate Variability in Chronic Fatigue Syndrome: A Randomized Cross-Over Study |
| Q39624619 | Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome. |
| Q48514268 | Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke |
| Q39703408 | Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients? |
| Q47904189 | Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome |
| Q37812748 | Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review |
| Q33753332 | Consensus guidelines for lumbar puncture in patients with neurological diseases |
| Q47150279 | Cortical mapping of painful electrical stimulation by quantitative electroencephalography: unraveling the time-frequency-channel domain. |
| Q48374884 | Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome |
| Q87417393 | Development and Pilot Testing of 24/7 In-Ambulance Telemedicine for Acute Stroke: Prehospital Stroke Study at the Universitair Ziekenhuis Brussel-Project |
| Q46083874 | Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity |
| Q57805393 | Disc Fragment Herniectomy Through a Facet Joint Quadrantectomy for Extraforaminal Lumbar Herniation: Technique and Results |
| Q91509493 | Effects of spinal cord stimulation on heart rate variability in patients with Failed Back Surgery Syndrome |
| Q48697496 | Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry |
| Q46436917 | Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. |
| Q43207022 | Excitatory amino acids and monoaminergic neurotransmitters in cerebrospinal fluid of acute ischemic stroke patients |
| Q48675053 | Fabry disease in a patient with Turner syndrome |
| Q51985658 | Fatal venous cerebral air embolism secondary to a disconnected central venous catheter. |
| Q27335647 | Feasibility of AmbulanCe-Based Telemedicine (FACT) study: safety, feasibility and reliability of third generation in-ambulance telemedicine |
| Q48826302 | Feasibility of cerebral magnetic resonance imaging in patients with externalised spinal cord stimulator. |
| Q36868874 | Feasibility, Reliability and Predictive Value Of In-Ambulance Heart Rate Variability Registration |
| Q39505666 | Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry. |
| Q49116429 | HF10 Therapy for Chronic Back Pain in Patients with Nonoperated Kyphoscoliosis: The Importance of Preoperative Assessment. |
| Q64237151 | Health Economic Evaluations of Digital Health Interventions for Secondary Prevention in Stroke Patients: A Systematic Review |
| Q38552503 | Heart rate variability and baroreceptor sensitivity in acute stroke: a systematic review. |
| Q50021433 | High-Density in Spinal Cord stimulation: Virtual Expert Registry (DISCOVER): Study Protocol for a Prospective Observational Trial. |
| Q49132503 | Insulin-like growth factor I serum levels influence ischemic stroke outcome. |
| Q92699731 | Interventions to promote work participation after ischaemic stroke: A systematic review |
| Q38211530 | Intracranial artery dissection. |
| Q46349306 | Intrathecal bupivacaine for arachnoiditis ossificans: a case report. |
| Q48782887 | Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban |
| Q48535098 | Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with apixaban |
| Q42873400 | Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran |
| Q54705204 | Left ventricular wall motion abnormalities: What can they tell us about stroke recurrence? |
| Q51752910 | Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke. |
| Q47807683 | Modified Rankin scale as a determinant of direct medical costs after stroke |
| Q48390207 | Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients |
| Q57805605 | Neurological Problems |
| Q35965334 | Neurological complications in renal failure: a review. |
| Q36795967 | Opinions and Beliefs About Telemedicine for Emergency Treatment During Ambulance Transportation and for Chronic Care at Home |
| Q44296121 | Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young |
| Q41754184 | Poststroke depression and its multifactorial nature: results from a prospective longitudinal study |
| Q49025533 | Pre-stroke use of beta-blockers does not affect ischaemic stroke severity and outcome |
| Q88771439 | PreSSUB II: The prehospital stroke study at the Universitair Ziekenhuis Brussel II |
| Q34199340 | Prediction of hospitalization duration for acute stroke in Belgium |
| Q38239311 | Prehospital stroke care: limitations of current interventions and focus on new developments |
| Q41967957 | Prehospital unassisted assessment of stroke severity using telemedicine: a feasibility study |
| Q47940187 | Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction. |
| Q48465579 | Prolyl carboxypeptidase activity decline correlates with severity and short-term outcome in acute ischemic stroke |
| Q44233553 | Psychosocial problems associated with depression at 18 months poststroke |
| Q40169733 | Relationship between pre-stroke cardiovascular medication use and stroke severity |
| Q57805565 | Response to Letter Regarding Belgian Fabry Study: Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular Disease |
| Q48223724 | Retrograde C0-C1 insertion of cervical plate electrode for chronic intractable neck and arm pain. |
| Q90998009 | Return to Work of Patients Treated With Spinal Cord Stimulation for Chronic Pain: A Systematic Review and Meta-Analysis |
| Q38203076 | Risk factors for poststroke depression: identification of inconsistencies based on a systematic review |
| Q39242543 | Spinal cord stimulation modulates cerebral function: an fMRI study |
| Q39227577 | Spinal cord stimulation modulates cerebral neurobiology: a proton magnetic resonance spectroscopy study |
| Q48149101 | Successful repetitive intravenous thrombolysis in a patient with recurrent brainstem infarctions due to megadolichobasilar ectasia |
| Q52147224 | The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke. |
| Q37484618 | The complexity of neurobiological processes in acute ischemic stroke |
| Q48421726 | The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome |
| Q57045606 | The relationship between Home-time, quality of life and costs after ischemic stroke: the impact of the need for mobility aids, home and car modifications on Home-time |
| Q43057551 | The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke |
| Q57805508 | The sNIHSS-4 predicts outcome in right and left anterior circulation strokes |
| Q47130483 | Time Gain Needed for In-Ambulance Telemedicine: Cost-Utility Model |
| Q51173303 | Twiddler's Syndrome and Neuromodulation-Devices: A Troubled Marriage. |
| Q57805515 | Unassisted Assessment of Stroke Severity Using Telemedicine |
| Q50783803 | Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke. |